Imagine trying to get people to eat healthier or quit smoking, but the standard advice just doesn't stick in certain regions. This project figures out why people in Eastern Europe ignore health guidelines and creates a personalized 'roadmap' to change that. It uses digital tools and community workshops to make cancer prevention feel personal rather than like a generic government lecture.
Standard cancer prevention messages are ignored in Eastern Europe due to socio-economic barriers and a lack of personalized communication. This leads to higher cancer rates from modifiable risks like smoking and obesity.
A 4P-CANcer algorithm, country-specific data dashboards, and a citizen-centric prevention model tested via living-labs.
If you are a health-tech developer dealing with low user engagement in CEE markets — this project developed the 4P-CANcer algorithm and personalized communication models that increase individual adherence to healthy behaviors.
If you are a PR agency dealing with ineffective public health campaigns — this project developed targeted communication campaigns and personal network analysis tools that refine how awareness is spread across 11 countries.
If you are an insurer dealing with high cancer-related costs in Eastern Europe — this project developed a citizen-centric prevention model that targets modifiable risk factors like obesity and smoking to reduce long-term claims.
Based on available project data, no specific pricing or cost structures for the algorithm have been disclosed.
The project is designed for multi-level scaling from individual (micro) to community (meso) and national (macro) levels across 11 countries.
Based on available project data, specific licensing terms for the 4P-CANcer algorithm and dashboards are not provided.
The project includes a comprehensive assessment of CPP legislation and policies, comparing Central and Eastern European countries with Western EU nations.
The project period runs from 2023-05-01 to 2027-04-30, indicating a multi-year development and testing phase.
The consortium is heavily weighted toward non-commercial entities, with 10 'Other' organizations, 4 universities, and 4 research centers. Only 1 industry partner and 2 SMEs are involved, resulting in a low industry ratio of 5%. This suggests the output is currently more academic and policy-oriented than commercially driven, though the inclusion of 11 countries provides a broad geographic data set for market entry.
Contact ASOCIATIA CENTRUL PENTRU INOVATIE IN MEDICINA in Romania
Contact us to explore licensing the 4P-CANcer algorithm for health-tech applications.
